<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37410793</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>Constructing a full, multiple-layer interactome for SARS-CoV-2 in the context of lung disease: Linking the virus with human genes and microbes.</ArticleTitle><Pagination><StartPage>e1011222</StartPage><MedlinePgn>e1011222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1011222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1011222</ELocationID><Abstract><AbstractText>The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in millions of deaths worldwide. The disease presents with various manifestations that can vary in severity and long-term outcomes. Previous efforts have contributed to the development of effective strategies for treatment and prevention by uncovering the mechanism of viral infection. We now know all the direct protein-protein interactions that occur during the lifecycle of SARS-CoV-2 infection, but it is critical to move beyond these known interactions to a comprehensive understanding of the "full interactome" of SARS-CoV-2 infection, which incorporates human microRNAs (miRNAs), additional human protein-coding genes, and exogenous microbes. Potentially, this will help in developing new drugs to treat COVID-19, differentiating the nuances of long COVID, and identifying histopathological signatures in SARS-CoV-2-infected organs. To construct the full interactome, we developed a statistical modeling approach called MLCrosstalk (multiple-layer crosstalk) based on latent Dirichlet allocation. MLCrosstalk integrates data from multiple sources, including microbes, human protein-coding genes, miRNAs, and human protein-protein interactions. It constructs "topics" that group SARS-CoV-2 with genes and microbes based on similar patterns of co-occurrence across patient samples. We use these topics to infer linkages between SARS-CoV-2 and protein-coding genes, miRNAs, and microbes. We then refine these initial linkages using network propagation to contextualize them within a larger framework of network and pathway structures. Using MLCrosstalk, we identified genes in the IL1-processing and VEGFA-VEGFR2 pathways that are linked to SARS-CoV-2. We also found that Rothia mucilaginosa and Prevotella melaninogenica are positively and negatively correlated with SARS-CoV-2 abundance, a finding corroborated by analysis of single-cell sequencing data.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Lou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Shaoke</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2626-5897</Identifier><AffiliationInfo><Affiliation>Program in Computational Biology &amp; Bioinformatics, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biophysics &amp; Biochemistry, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Mingjun</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6341-4284</Identifier><AffiliationInfo><Affiliation>School of Electronic Engineering and Computer Science, Queen Mary University of London, Mile End Road, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tianxiao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Program in Computational Biology &amp; Bioinformatics, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biophysics &amp; Biochemistry, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Weihao</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-7480-8112</Identifier><AffiliationInfo><Affiliation>Program in Computational Biology &amp; Bioinformatics, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biophysics &amp; Biochemistry, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cevasco</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5466-0181</Identifier><AffiliationInfo><Affiliation>Program in Computational Biology &amp; Bioinformatics, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yucheng T</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerstein</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9746-3719</Identifier><AffiliationInfo><Affiliation>Program in Computational Biology &amp; Bioinformatics, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biophysics &amp; Biochemistry, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics &amp; Data Science Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics &amp; Data Science, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DA051906</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37410793</ArticleId><ArticleId IdType="pmc">PMC10325097</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1011222</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-22-00575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181(4):914&#x2013;21 e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179501</ArticleId><ArticleId IdType="pubmed">32330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al.. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265&#x2013;9. doi: 10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Malone B, Llewellyn E, Grasso M, Shelton PMM, Olinares PDB, et al.. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex. Cell. 2020;182(6):1560&#x2013;73 e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386476</ArticleId><ArticleId IdType="pubmed">32783916</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan T, Arya S, Chan SH, Qi S, Dai N, Misra A, et al.. Structural basis of RNA cap modification by SARS-CoV-2. Nat Commun. 2020;11(1):3718. doi: 10.1038/s41467-020-17496-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17496-8</ArticleId><ArticleId IdType="pmc">PMC7381649</ArticleId><ArticleId IdType="pubmed">32709886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270&#x2013;84. doi: 10.1038/s41579-022-00713-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, et al.. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370(6521). doi: 10.1126/science.abe9403</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9403</ArticleId><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al.. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459&#x2013;68. doi: 10.1038/s41586-020-2286-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Redin C, Thorball CW, Fellay J. Host genomics of SARS-CoV-2 infection. Eur J Hum Genet. 2022;30(8):908&#x2013;14. doi: 10.1038/s41431-022-01136-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-022-01136-4</ArticleId><ArticleId IdType="pmc">PMC9244159</ArticleId><ArticleId IdType="pubmed">35768520</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Guo M, Tian X, Wang X, Yang X, Wu P, et al.. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. Med. 2021;2:99&#x2013;112.e7. doi: 10.1016/j.medj.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn RA, Belk JA, Qi Y, Bertozzi CR, Wilen CB, Satpathy AT. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7951565</ArticleId><ArticleId IdType="pubmed">33743211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, et al.. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21(9):1107&#x2013;18. doi: 10.1038/s41590-020-0762-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0762-x</ArticleId><ArticleId IdType="pubmed">32788748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng DL, Granados AC, Santos YA, Servellita V, Goldgof GM, Meydan C, et al.. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood. Sci Adv. 2021;7(6). doi: 10.1126/sciadv.abe5984</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe5984</ArticleId><ArticleId IdType="pmc">PMC7857687</ArticleId><ArticleId IdType="pubmed">33536218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wen W, Fan X, Hou W, Su B, Cai P, et al.. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184(7):1895&#x2013;913 e19. doi: 10.1016/j.cell.2021.01.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.053</ArticleId><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Li B, Ma H, Wang X, Cai P, Yu Q, et al.. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun. 2020;11(1):3924. doi: 10.1038/s41467-020-17834-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17834-w</ArticleId><ArticleId IdType="pmc">PMC7413381</ArticleId><ArticleId IdType="pubmed">32764665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols RG, Davenport ER. The relationship between the gut microbiome and host gene expression: a review. Hum Genet. 2021;140(5):747&#x2013;60. doi: 10.1007/s00439-020-02237-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-020-02237-0</ArticleId><ArticleId IdType="pmc">PMC7680557</ArticleId><ArticleId IdType="pubmed">33221945</ArticleId></ArticleIdList></Reference><Reference><Citation>Maudet C, Mano M, Sunkavalli U, Sharan M, Giacca M, Forstner KU, et al.. Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection. Nat Commun. 2014;5:4718. doi: 10.1038/ncomms5718</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5718</ArticleId><ArticleId IdType="pubmed">25146723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaei R, Mahdavi F, Badrzadeh F, Hosseini-Fard SR, Heidary M, Jeda AS, et al.. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Int Immunopharmacol. 2021;90:107204. doi: 10.1016/j.intimp.2020.107204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107204</ArticleId><ArticleId IdType="pmc">PMC7664359</ArticleId><ArticleId IdType="pubmed">33221169</ArticleId></ArticleIdList></Reference><Reference><Citation>Arisan ED, Dart A, Grant GH, Arisan S, Cuhadaroglu S, Lange S, et al.. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities. Viruses. 2020;12(6). doi: 10.3390/v12060614</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12060614</ArticleId><ArticleId IdType="pmc">PMC7354481</ArticleId><ArticleId IdType="pubmed">32512929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarinejad-Farsangi S, Jazi MM, Rostamzadeh F, Hadizadeh M. High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis. Noncoding RNA Res. 2020;5(4):222&#x2013;31. doi: 10.1016/j.ncrna.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7680021</ArticleId><ArticleId IdType="pubmed">33251388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P, Giladi A, Liu Y, Bendjelal Y, Xu G, David E, et al.. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell. 2020;181(7):1475&#x2013;88 e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205692</ArticleId><ArticleId IdType="pubmed">32479746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma PV, Thaiss CA. Host-Microbiome Interactions in the Era of Single-Cell Biology. Front Cell Infect Microbiol. 2020;10:569070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7591464</ArticleId><ArticleId IdType="pubmed">33163417</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravorty S, Yan B, Wang C, Wang L, Quaid JT, Lin CF, et al.. Integrated Pan-Cancer Map of EBV-Associated Neoplasms Reveals Functional Host-Virus Interactions. Cancer Res. 2019;79(23):6010&#x2013;23. doi: 10.1158/0008-5472.CAN-19-0615</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-19-0615</ArticleId><ArticleId IdType="pmc">PMC6891172</ArticleId><ArticleId IdType="pubmed">31481499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayama G, Priya S, Niccum DE, Khoruts A, Blekhman R. Interactions between the gut microbiome and host gene regulation in cystic fibrosis. Genome Med. 2020;12(1):12. doi: 10.1186/s13073-020-0710-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-020-0710-2</ArticleId><ArticleId IdType="pmc">PMC6988342</ArticleId><ArticleId IdType="pubmed">31992345</ArticleId></ArticleIdList></Reference><Reference><Citation>Priya S, Burns MB, Ward T, Mars RAT, Adamowicz B, Lock EF, et al.. Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration. Nat Microbiol. 2022;7(6):780&#x2013;95. doi: 10.1038/s41564-022-01121-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01121-z</ArticleId><ArticleId IdType="pmc">PMC9159953</ArticleId><ArticleId IdType="pubmed">35577971</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffnagle GB. Another piece in the &#x2019;research mosaic&#x2019; that describes the role of the lung microbiome in COPD. Thorax. 2016;71(9):777&#x2013;8. doi: 10.1136/thoraxjnl-2015-207415</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-207415</ArticleId><ArticleId IdType="pubmed">27435609</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C, Bushman FD, Collman RG. Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance. Microbiome. 2022;10(1):165. doi: 10.1186/s40168-022-01342-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01342-8</ArticleId><ArticleId IdType="pmc">PMC9532226</ArticleId><ArticleId IdType="pubmed">36195943</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, et al.. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol. 2021;4(1):240. doi: 10.1038/s42003-021-01796-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01796-w</ArticleId><ArticleId IdType="pmc">PMC7893062</ArticleId><ArticleId IdType="pubmed">33603076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2022:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, et al.. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7(1):143. doi: 10.1038/s41392-022-00986-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6). doi: 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43(4):268&#x2013;70. doi: 10.1016/j.it.2022.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou S, Li T, Kong X, Zhang J, Liu J, Lee D, et al.. TopicNet: a framework for measuring transcriptional regulatory network change. Bioinformatics. 2020;36(Suppl_1):i474&#x2013;i81. doi: 10.1093/bioinformatics/btaa403</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa403</ArticleId><ArticleId IdType="pmc">PMC7355251</ArticleId><ArticleId IdType="pubmed">32657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauwaert M, Druwe P, Depuydt P. Meningitis in a patient with neutropenia due to Rothia mucilaginosa: a case report. J Med Case Rep. 2019;13(1):84. doi: 10.1186/s13256-018-1947-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-018-1947-x</ArticleId><ArticleId IdType="pmc">PMC6413452</ArticleId><ArticleId IdType="pubmed">30857551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YW, Schmieder R, Haynes M, Furlan M, Matthews TD, Whiteson K, et al.. Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic data. PLoS One. 2013;8(5):e64285. doi: 10.1371/journal.pone.0064285</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064285</ArticleId><ArticleId IdType="pmc">PMC3667864</ArticleId><ArticleId IdType="pubmed">23737977</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmarawati TP, Rosyid AN, Suryantoro SD, Mahdi BA, Windradi C, Wulaningrum PA, et al.. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya. F1000Res. 2021;10:113. doi: 10.12688/f1000research.31645.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.31645.2</ArticleId><ArticleId IdType="pmc">PMC8030114</ArticleId><ArticleId IdType="pubmed">33868645</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran V, Lawrence H, Lansbury LE, Webb K, Safavi S, Zainuddin NI, et al.. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol. 2021;70(4). doi: 10.1099/jmm.0.001350</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001350</ArticleId><ArticleId IdType="pmc">PMC8289210</ArticleId><ArticleId IdType="pubmed">33861190</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeza Martinez C, Zamora Molina L, Garcia Sevila R, Gil Carbonell J, Ramos Rincon JM, Martin Serrano C. Rothia mucilaginosa pneumonia in an immunocompetent patient. Arch Bronconeumol. 2014;50(11):493&#x2013;5. doi: 10.1016/j.arbres.2013.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2013.12.010</ArticleId><ArticleId IdType="pubmed">24568756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Liu T, Liu BC, Liu CT. Severe Pneumonia Advanced to Lung Abscess and Empyema Due to Rothia Mucilaginosa in an Immunocompetent Patient. Am J Med Sci. 2020;359(1):54&#x2013;6. doi: 10.1016/j.amjms.2019.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2019.10.015</ArticleId><ArticleId IdType="pubmed">31785769</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363&#x2013;74. doi: 10.1111/imm.12760</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12760</ArticleId><ArticleId IdType="pmc">PMC5506432</ArticleId><ArticleId IdType="pubmed">28542929</ArticleId></ArticleIdList></Reference><Reference><Citation>Valeri A, Chiricosta L, Gugliandolo A, Biasin M, Avanzini MA, Calcaterra V, et al.. SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes. Int J Mol Sci. 2021;22(21). doi: 10.3390/ijms222111814</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111814</ArticleId><ArticleId IdType="pmc">PMC8584055</ArticleId><ArticleId IdType="pubmed">34769246</ArticleId></ArticleIdList></Reference><Reference><Citation>Munnur D, Teo Q, Eggermont D, Lee HHY, Thery F, Ho J, et al.. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection. Nat Immunol. 2021;22(11):1416&#x2013;27. doi: 10.1038/s41590-021-01035-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01035-8</ArticleId><ArticleId IdType="pubmed">34663977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, et al.. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol. 2021;148(3):732&#x2013;8 e1. doi: 10.1016/j.jaci.2021.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.06.024</ArticleId><ArticleId IdType="pmc">PMC8252701</ArticleId><ArticleId IdType="pubmed">34224783</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz M, Torre D, Lozano-Ojalvo D, Tan AT, Tabaglio T, Mzoughi S, et al.. Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR. Nat Biotechnol. 2022;40(11):1680&#x2013;9. doi: 10.1038/s41587-022-01347-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01347-6</ArticleId><ArticleId IdType="pmc">PMC10603792</ArticleId><ArticleId IdType="pubmed">35697804</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris A, Reijnders TDY, Reijm M, Hollander JC, de Buck K, Schuurman AR, et al.. Enrichment of CCR6(+) CD8(+) T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19. Eur J Immunol. 2021;51(6):1535&#x2013;8. doi: 10.1002/eji.202049046</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202049046</ArticleId><ArticleId IdType="pmc">PMC8250259</ArticleId><ArticleId IdType="pubmed">33768543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection. Nat Immunol. 2021;22(11):1360&#x2013;2. doi: 10.1038/s41590-021-01056-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01056-3</ArticleId><ArticleId IdType="pubmed">34671145</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al.. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(15):713&#x2013;20. doi: 10.1093/cid/ciaa203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa203</ArticleId><ArticleId IdType="pmc">PMC7108196</ArticleId><ArticleId IdType="pubmed">32129843</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, et al.. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun. 2020;11(1):6319. doi: 10.1038/s41467-020-20139-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20139-7</ArticleId><ArticleId IdType="pmc">PMC7725958</ArticleId><ArticleId IdType="pubmed">33298930</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al.. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al.. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42(Database issue):D633&#x2013;42. doi: 10.1093/nar/gkt1244</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1244</ArticleId><ArticleId IdType="pmc">PMC3965039</ArticleId><ArticleId IdType="pubmed">24288368</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, et al.. GenBank. Nucleic Acids Res. 2013;41(Database issue):D36&#x2013;42. doi: 10.1093/nar/gks1195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1195</ArticleId><ArticleId IdType="pmc">PMC3531190</ArticleId><ArticleId IdType="pubmed">23193287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozowsky J, Kitchen RR, Park JJ, Galeev TR, Diao J, Warrell J, et al.. exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling. Cell Syst. 2019;8(4):352&#x2013;7 e3. doi: 10.1016/j.cels.2019.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2019.03.004</ArticleId><ArticleId IdType="pmc">PMC7079576</ArticleId><ArticleId IdType="pubmed">30956140</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15(3):R46. doi: 10.1186/gb-2014-15-3-r46</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2014-15-3-r46</ArticleId><ArticleId IdType="pmc">PMC4053813</ArticleId><ArticleId IdType="pubmed">24580807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>